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Effective major histocompatibility complex-II (MHC-
II) antigen presentation from phagocytosed particles
requires phagosome-intrinsic Toll-like receptor (TLR)
signaling, but the molecular mechanisms underlying
TLR delivery to phagosomes and how signaling regu-
lates antigen presentation are incompletely under-
stood. We show a requirement in dendritic cells
(DCs) for adaptor protein-3 (AP-3) in efficient
TLR recruitment to phagosomes andMHC-II presen-
tation of antigens internalized by phagocytosis
but not receptor-mediated endocytosis. DCs from
AP-3-deficient pearl mice elicited impaired CD4+
T cell activation and Th1 effector cell function to
particulate antigen in vitro and to recombinant
Listeria monocytogenes infection in vivo. Whereas
phagolysosome maturation and peptide:MHC-II
complex assembly proceeded normally in pearl
DCs, peptide:MHC-II export to the cell surface was
impeded. This correlated with reduced TLR4 recruit-
ment and proinflammatory signaling from phago-
somes by particulate TLR ligands. We propose that
AP-3-dependent TLR delivery from endosomes to
phagosomes and subsequent signaling mobilize
peptide:MHC-II export from intracellular stores.
INTRODUCTION
Professional phagocytes ingest and process particulate matter
for distinct purposes. During infection, most phagocytes
primarily function to eliminate pathogens, but dendritic cells
(DCs) balance pathogen destruction with antigen (Ag) preserva-
tion for presentation to Ag-specific T cells. This balance requires782 Immunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc.both selective recruitment of factors that modify the nascent
phagosome environment (Savina and Amigorena, 2007) and
selective activation of maturation programs via innate immune
receptors such as Toll-like receptors (TLRs) (Blander and
Medzhitov, 2006b). Although general features of phagosome
maturation have been intensively studied (Flannagan et al.,
2009; Kinchen and Ravichandran, 2008), the molecular mecha-
nisms underlying selective factor recruitment to phagosomes
in DCs and their integration with TLR signaling have been largely
unexplored.
Several factors required for organelle maturation have been
identified by studying genetic disorders of organelle biogenesis.
For example, protein complexes required for the biogenesis
of lysosome-related organelles (LROs)—cell type-specific
organelles that derive from the endocytic pathway (Raposo
et al., 2007)—are disrupted in patients with Hermansky-Pudlak
syndrome (HPS), a group of genetic diseases characterized by
oculocutaneous albinism, excessive bleeding, and other variable
symptoms (Huizing et al., 2008; Wei, 2006). The coat protein
complex adaptor protein-3 (AP-3), for which the b3A subunit is
genetically inactivated in HPS type 2 and its mouse model, pearl
(Dell’Angelica et al., 1999; Feng et al., 1999), sorts integral
membrane cargoes primarily from early endosomes toward
lysosomes, LROs, or related compartments (Dell’Angelica,
2009); hence, LROs such as melanosomes and platelet-dense
granules are malformed in AP-3-deficient patients and animals
(Huizing et al., 2008; Wei, 2006). HPS type 2 patients also suffer
from recurrent bacterial and viral infections. This immunodefi-
ciency has been correlated to defective polarization of lytic
granules in cytotoxic T cells (Clark et al., 2003) and natural
killer cells (Fontana et al., 2006) and impaired CD1-dependent
lipid Ag presentation (Briken et al., 2002; Sugita et al., 2002).
Neutropenia is also observed in most patients (Huizing et al.,
2002; Jung et al., 2006; Shotelersuk et al., 2000) but cannot
solely account for recurrent bacterial infections that persist
even after neutrophil counts are restored by granulocyte-colony
stimulating factor treatment (Enders et al., 2006; Wenham et al.,
Figure 1. AP-3 Is Not Required for Efficient OVA
Cross-Presentation
BMDCs from WT, pearl, or gp91phox-deficient Cybb/
mice were incubated for 30 min with the indicated
concentrations of OVA257-264 peptide (A, B), soluble OVA
(C, D), or latex beads conjugated to 10 mg/ml of
a OVA:BSA mixture in the indicated ratios (E, F), then fixed
and cocultured with OT-I cells for 18 hr.
(A, C, E) CD69 expression on OT-I cells was assessed by
flow cytometry. Shown are the percentages of vb5+ T cells
that expressed CD69.
(B, D, F) IL-2 production by OT-I cells was measured by
ELISA on the culture supernatants.
Data represent mean ± SD of three experiments
performed in duplicate. *p < 0.05; **p < 0.01. See also
Figure S1.
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AP-3, TLR, and MHC-II Presentation from Phagosomes2010). Nevertheless, the hemophagocytic lymphohistiocytosis
observed in some patients implies a defect in phagocyte
function and suggests that AP-3 might control other phagocyte
processes.
AP-3 has recently been linked to TLR signaling in a DC subset.
In plasmacytoid DCs (pDCs), AP-3 is required to stimulate
type I interferon production by mobilizing activated TLR7 and
TRL9 from endosomes to a specialized LRO (Blasius et al.,
2010; Sasai et al., 2010). This pathway primarily influences anti-
viral immunity, but it raises the possibility that AP-3 might more
generally regulate TLR trafficking in DCs—such as TLR4 delivery
from endosomes to maturing phagosomes (Husebye et al.,
2010).
Here, we tested whether phagosome maturation and conse-
quent Ag presentation in DCs is altered in pearl mice, which
lack functional AP-3 complexes, and in an unrelated mouse
HPS model. We show that pearl DCs are impaired in both major
histocompatibility complex (MHC) class II (MHC-II) presentation
of phagocytosed Ag and proinflammatory TLR signaling from
phagosomes. Our data support a requirement for AP-3 in phag-
osome-intrinsic TLR signaling and consequent delivery of
peptide-loaded MHC-II to the plasma membrane and suggest
that recurrent bacterial infections in HPS type 2 patients might
in part reflect a defect in TLR-dependent MHC-II presentation
by DCs and consequent proinflammatory responses.Immunity 36RESULTS
AP-3 Is Not Required for Efficient
Cross-Presentation of Ovalbumin
Fusion of nascent phagosomes in DCs with an
‘‘inhibitory LRO,’’ which harbors the gp91phox
subunit of the phagocyte NADPH oxidase
(NOX2), enables cross-presentation of phago-
cytosed Ag by MHC class I (MHC-I) (Jancic
et al., 2007; Mantegazza et al., 2008; Savina
et al., 2006). Because other LROs are mal-
formed in HPS, we tested for impaired cross-
presentation in DCs from the AP-3-deficient
pearl mouse model of HPS type 2 and the pallid
mousemodel of HPS type 9,which lacks a sepa-
rate protein complex called biogenesis of lyso-
some related organelle complex 1 (BLOC-1)(Cullinane et al., 2011; Wei, 2006). As shown previously (Sasai
et al., 2010), wild-type C57BL/6 (WT), pearl, and pallid bone
marrow cells differentiated comparably to DCs in response to
GM-CSF, as assessed by surface expression of CD11c,
CD11b, MHC-I, MHC-II, and CD86 and by soluble LPS-induced
upregulation of MHC-I, MHC-II, and CD86 (Figures S3A and S3B
available online). Likewise, WT and pearl mice had similarly
composed splenic populations of CD11chiB220lo conventional
DCs, their CD11chiCD8hi and CD11chiCD8lo DC subsets, and
CD11cintB220hi pDCs (and of monocytes, macrophages, B cells,
and NK cells; Figures S3D–S3H). Thus, neither BLOC-1 nor AP-3
is required for DC differentiation in vitro or in vivo.
To test whether AP-3 or BLOC-1 is required to cross-present
the model Ag ovalbumin (OVA), bone marrow-derived DCs
(BMDCs) were pulsed with increasing doses of either OVA257-264
peptide, soluble OVA, or particulate OVA conjugated to polysty-
rene beads (OVA beads) and then cocultured with OVA257-264-
specific, H-2Kb-restricted OT-I T cells. The dose-response curve
to induce OT-I CD69 expression or IL-2 production was identical
for WT, pearl, and pallid BMDCs with each source of antigen
(Figures 1 and S1A–S1C). Similar results were obtained with
splenic CD11chi DCs isolated from WT and pearl mice (Figures
S2A–S2C). In contrast, cross-presentation of both soluble and
particulate OVA by gp91phox-deficient (Cybb/) BMDCs was
impaired (Figures 1C–1F and S1) as expected (Savina et al.,, 782–794, May 25, 2012 ª2012 Elsevier Inc. 783
Figure 2. AP-3 Is Selectively Required for Optimal
MHC-II Presentation of Phagocytosed Ag
BMDCs from WT or pearl mice were incubated for 30 min
with the indicated concentrations of OVA323-339 peptide
(A, B), soluble OVA (C, D), or OVA:BSA-conjugated latex
beads (E, F, G) and then cocultured with OT-II cells for
18 hr.
(A, C, E) CD69 expression by OT-II cells was assessed by
flow cytometry. Shown are the percentages of vb5+ T cells
that expressed CD69.
(F) Representative experiment showing CD69 upregula-
tion on OT-II cells after phagocytosis of OVA:BSA beads
by BMDCs. Shown are the percentages of vb5+ cells that
expressed CD69.
(B, D, G) IL-2 production by OT-II cells was measured by
ELISA on the coculture supernatants.
Data in (A)–(E) and (G) represent mean ± SD of five
experiments performed in duplicate. *p < 0.05. See also
Figures S1 and S2.
Immunity
AP-3, TLR, and MHC-II Presentation from Phagosomes2006). Thus, neither AP-3 nor BLOC-1 is required for Ag cross-
presentation.
AP-3 Is Required for Optimal MHC-II Presentation
of Phagocytosed Ag and CD4+ T Cell Differentiation
To test whether AP-3 is required for MHC-II presentation,
BMDCs or splenic DCs from WT, pearl, or pallid mice were
pulsed with increasing concentrations of OVA323-339 peptide or
soluble or particulate OVA and then cocultured with OVA323-339-
specific, I-Ab-restricted OT-II T cells. The dose-response curves
of OT-II CD69 expression or IL-2 production to OVA peptide
or soluble OVA (Figures 2A–2D, S1D, S1E, S2D, and S2E) pre-
sented by WT, pearl, and pallid DCs were identical, supporting
reports (Caplan et al., 2000; Sevilla et al., 2001) that AP-3 was784 Immunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc.dispensable for MHC-II trafficking and showing
that neither AP-3 nor BLOC-1 was required
for processing and presentation of Ag internal-
ized by receptor-mediated endocytosis. By
contrast, OT-II activation was significantly
impaired after coculture with pearl DCs pulsed
with OVA beads relative to similarly pulsed WT
or pallid BMDCs (Figures 2E–2G, S1F, and
S2F). This did not reflect a defect in phagocy-
tosis, because WT, pearl, and pallid BMDCs
ingested fluorophore-conjugated beads to a
similar extent (Figure S3C). Thus, whereas
BLOC-1 is dispensable, AP-3 is required for
effective MHC-II presentation of OVA only
when captured by phagocytosis.
To determine whether the impaired T cell acti-
vation correlated with altered downstreamOT-II
T cell effector function, we evaluated production
of the Th1 cytokine IFN-g and the Th2 cytokine
IL-4 in response to Ag-pulsed WT or pearl
BMDCs. The fraction of cytokine-producing
OT-II cells was identical after coculture with
peptide- or soluble OVA-pulsed WT or pearl
BMDCs (Figures 3A–3D). However, whereas
WT and pearl BMDCs pulsed with OVA beadselicited a similar IL-4 response, IFN-g production was signifi-
cantly impaired in response to pearl BMDCs pulsed with OVA
beads at all concentrations (Figures 3E–3G). Thus, after Ag
uptake by phagocytosis, pearl BMDCs elicit a T cell response
that is selectively defective in IFN-g secretion.
AP-3 Is Required for Efficient MHC-II Presentation
and Th1 Cell Differentiation after Listeria Infection
To determine whether AP-3 in conventional DCs is required
in vivo for efficient T cell responses to phagocytosed bacteria,
we exploited a recombinant OVA-secreting Listeria monocyto-
genes strain (Foulds et al., 2002) (referred to here as rLM-OVA)
in the Dhlymutant, which lacks listeriolysin and is thus restricted
to phagosomes. BMDCs from WT or pearl mice were equally
Figure 3. AP-3 Is Required for the Induction of an
Optimal Th1 Cell Response to Phagocytosed Ag
BMDCs from WT or pearl mice were incubated with the
indicated concentrations of OVA323-339 peptide (A, B),
soluble OVA (C, D), or OVA:BSA-conjugated latex beads
(E–G), then cocultured with OT-II cells for 3 days. T cells
were then restimulated with either CD3 and CD28 anti-
bodies or with PMA and ionomycin in the presence of
brefeldin A for 5 hr, labeled for intracellular IFN-g (A, C,
E, F) or IL-4 (B, D, G), and analyzed by flow cytometry.
Shown are the percentages of vb5+ T cells expressing
each cytokine. Results represent mean ± SD of three
experiments performed in duplicate. *p < 0.05; **p < 0.01.
(F) Representative experiment showing intracellular IFN-g
production by OT-II cells. Indicated are the percentages of
vb5+ OT-II cells that are IFN-g+.
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AP-3, TLR, and MHC-II Presentation from Phagosomessusceptible to infection and ingested similar numbers of CFSE-
labeled rLM-OVA (Figures S4A and S4B). Nevertheless, whereas
pearl BMDCs that were either infected with rLM-OVA or exposed
to soluble OVA stimulatedMHC-I-restrictedOT-I T cells as effec-
tively as did wild-type BMDCs (Figure S4C), rLM-OVA-infected
pearl BMDCs induced less OT-II T cell activation and subse-
quent IFN-g production (Figures S4D–S4G). Thus, MHC-II
presentation of phagocytosed Ag on both indigestible latex
beads and bacteria is impaired in pearl DCs.
To test whether Ag presentation by pearl DCs was impaired
in vivo, we first assessed the ability of splenic DCs isolated
from immunized WT or pearl mice to stimulate OT-I or OT-II cells
in vitro. One day after immunization with OVA, splenic DCs from
WT or pearl mice stimulated CD69 expression on OT-II cells
equally well (Figures 4A and 4C), confirming that pearl DCs effec-Immunity 36tively processed and presented soluble Ag
in vivo. By contrast, splenic DCs from pearl
mice 1 or 3 days after infection with rLM-OVA
stimulated OT-II cells less efficiently than did
WT DCs (Figures 4A–4C), despite eliciting
a similar OT-I cell response (Figures 4B and
4D; note the low background stimulation by
DCs immunized with the parental Dhly LM
mutant, referred to here as rLM). This confirms
that MHC-II presentation of phagocytosed Ag
in vivo is specifically impaired in pearl splenic
DCs. To probe T cell activation during an infec-
tion, we examined the response of adoptively
transferred OT-II T cells upon infection of WT
or pearl micewith rLM-OVA or rLM as a negative
control. OT-II cells harvested from spleens (Fig-
ures 4E and 4F) or lymph nodes (not shown) of
WT mice were robustly activated (expressed
CD69) 24 hr after infection with rLM-OVA or
soluble OVA but not with rLM. By contrast,
OT-II activation at this timepoint in pearlmice in-
fected with rLM-OVA was dramatically impaired
and barely above background. Moreover,
whereas a substantial fraction of OT-II cells har-
vested from spleen or lymph node of WT mice
8 days postinfection with rLM-OVA produced
IFN-g and IL-4 upon restimulation in vitro, cellsharvested from pearl mice produced only IL-4 at levels above
background (Figures 4G and 4H). Thus, MHC-II presentation of
phagocytosed antigen and Th1 cell polarization are severely
impaired in pearl mice. Although the data do not exclude an influ-
ence of other AP-3-expressing cell types on IFN-g secretion, the
similarity between in vivo and in vitro T cell stimulatory responses
suggests that this reflects reduced Ag presentation and/or
proinflammatory cytokine production (see below) by pearl DCs.
Pearl DCs Express Fewer Cell Surface MHC-II
Complexes with Peptides Derived from Phagocytosed
Antigen
To understand how AP-3 regulates MHC-II presentation of
phagocytosed Ags, we quantified surface peptide:MHC-II
complexes by using Yae, an antibody that recognizes an, 782–794, May 25, 2012 ª2012 Elsevier Inc. 785
Figure 4. AP-3 Is Required for Efficient
MHC-II Presentation by Splenic DCs and
for Th1 Cell Differentiation of OT-II T Cells
during Infection with OVA-Expressing
Listeria
(A–D) Splenic DCs were isolated from WT and
pearl mice 1 day (A) or 3 days (B) after immuniza-
tion with rLM, rLM-OVA, or OVA and cocultured
in vitro with OT-I or OT-II cells. CD69 expression
on T cells was analyzed after 18 hr. Shown are the
percentages of vb5+ T cells that expressed CD69
in representative experiments (A, B) and the
mean ± SD from three experiments (C, D).
(E–H) CFSE-labeled CD45.1+ OT-II cells were
adoptively transferred into CD45.2+ WT and pearl
mice, and mice were infected with rLM or rLM-
OVA 24 hr later.
(E and F) CD69 upregulation by CD45.1+CFSE+
OT-II cells from spleen single-cell suspensions
was assessed by flow cytometry 18 hr after
infection.
(E) Shown are the percentages of CFSE-positive
T cells that expressed CD69.
(F) Representative experiment showing percent-
ages of CFSE+-CD69+ OT-II cells after gating on
CD45.1+ cells.
(G and H) 8 days after infection, single-cell
suspensions of harvested spleens were restimu-
lated for 5 hr with OVA323-339 peptide and CD3
antibody in the presence of brefeldin A, labeled for
intracellular IFN-g (G) or IL-4 (H), and analyzed by
flow cytometry. Data representmean ± SD of three
experiments with five animals per group.
*p < 0.05; **p < 0.01. See also Figure S4.
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AP-3, TLR, and MHC-II Presentation from PhagosomesEa-derived peptide complexed with I-Ab (Rudensky et al., 1991).
BMDCs from WT and pearl mice were pulsed with soluble or
bead-conjugated Ea-GFP-His6 fusion proteins (Pape et al.,
2007), and surface Ea:I-Ab complexes were detected by Yae
via flow cytometry (Figures 5A–5F). After exposure to either Ag
source, the percentage of WT and pearl BMDCs that expressed
surface Ea:I-Ab complexes rose linearly over time. However,
although an identical percentage of WT and pearl BMDCs
expressed surface Ea:I-Ab complexes after exposure to soluble
Ea fusion protein (Figures 5A and 5B), the percentage of surface
Yae-positive pearl BMDCs was significantly reduced at all time
points relative to WT BMDCs after exposure to particulate fusion
protein (Figures 5C and 5D). These data were supported in anal-786 Immunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc.yses of OT-II restimulation by DCs that
were fixed 0–6 hr after OVA bead phago-
cytosis (Figure S5A and data not shown)
and indicate that the reduced presenta-
tion of phagocytosed Ags by pearl DCs
reflects reduced surface expression of
peptide:MHC-II complexes.
AP-3 Is Required for Efficient
Delivery of Peptide:MHC-II
Complexes to the DC Surface
To test whether the reduced presentation
of phagocytosed Ag by pearl BMDCs re-flected defective Ag processing, we analyzed phagosomal
degradative capacity. The pH of phagosomes harboring fluor-
conjugated polystyrene beads was initially higher in pearl
than in WT BMDCs and remained slightly more alkaline over
time (Figure S5C), even after LPS stimulation (not shown).
However, a similar pattern was observed in pallid BMDCs (Fig-
ure S5C), indicating that the pH change alone did not impair
Ag processing. Moreover, the rates of active cathepsins B, L,
and S recruitment to phagosomes (Figures S5D–S5F) and of
OVA degradation on OVA beads were identical in WT and
pearl BMDCs (Figure S5G; whereas OVA in Tlr4/ BMDC phag-
osomes was degraded more slowly, as expected) (Blander
and Medzhitov, 2004). Based on these observations, pearl
Figure 5. Defective Presentation of Phago-
cytosed Ag in Pearl DCs Reflects Inefficient
Trafficking of Peptide:MHC-II Complexes to
the Cell Surface
BMDCs from WT and pearl mice were pulsed with
soluble EaGFP fusion protein (A, B) or EaGFP
beads (C–F) for 30 min, washed, and chased for
the indicated times.
(A–D) Surface expression of Ea52-68:I-A
b com-
plexes was analyzed by flow cytometry using Yae.
(A and C) Shown are the percentages of CD11c+
BMDCs that were Ea52-68:I-A
b+ over time.
(B and D) Representative experiment showing
percentage of CD11c+ cells expressing surface
Ea52-68:I-A
b complexes after the pulse. Also
shown in (D) is a control in which cells were
exposed to OVA beads instead of EaGFP beads
and chased for 6 hr.
(E) Surface Ea52-68:I-A
b complexes were blocked
with unlabeled Yae, then cells were fixed and
permeabilized and intracellular Ea52-68:I-A
b
complexes were detected by flow cytometry using
biotinylated Yae. Shown are the percentages of
CD11c+ BMDCs that were Ea52-68:I-A
b+.
(F) Cells harvested at 4 hr or 18 hr after the pulse
were fixed, permeabilized, and analyzed by
immunofluorescence microscopy with Yae and
secondary antibody (top) and by phase contrast to
visualize the beads (bottom).
Data in (A), (C), and (E) represent the mean ± SD
from three experiments performed in duplicate.
*p < 0.05; **p < 0.01. See also Figure S5.
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AP-3, TLR, and MHC-II Presentation from PhagosomesBMDCs efficiently degrade Ag. Consistently, intracellular Ea:I-Ab
complexes formed effectively in pearl BMDCs after phagocy-
tosis of particulate Ea fusion protein. However, they were
retained intracellularly up to 18 hr later (Figure 5E). By immuno-
fluorescence microscopy, the Ea:I-Ab complexes accumulated
in both WT and pearl BMDCs shortly after phagocytosis
largely in punctate structures throughout the cytoplasm (Fig-
ure 5F). These punctate structures did not overlap with markers
of lysosomes or early or late endosomes (not shown). However,
whereas in WT cells the Ea:I-Ab complexes were translocated
to the plasma membrane by 4–18 hr, they were retained within
the punctate structures in pearl BMDCs (Figure 5F). This sug-
gests that AP-3 is required to optimize peptide:MHC-II complex
transport from phagosomes or postphagosomal compartments
to the plasma membrane.Immunity 36, 782–AP-3 Is Required for Efficient
Recruitment of TLR4 and MyD88
to Phagosomes
Because AP-3 targets cargoes to late
endosomal compartments and is dis-
pensable for MHC-II presentation of non-
phagocytosed Ag, it probably does not
function directly in peptide:MHC-II trans-
port to the cell surface. Because our OVA
and Ea-GFP bead preparations probably
contain the TLR4 ligand LPS, and rLM
stimulates other TLRs, we reasoned that
TLR signaling—a known intrinsic require-ment for phagosome maturation and Ag processing (Blander
and Medzhitov, 2006b)—might also be required for effective
surface delivery of phagosome-derived peptide:MHC-II com-
plexes. TLR4 is recruited to phagosomes from recycling endo-
somes (Husebye et al., 2010), from which AP-3 might function
(Peden et al., 2004); we therefore tested whether TLR4 recruit-
ment to and activation on phagosomes was dysregulated in
pearl DCs. WT, pearl, or pallid BMDCs were pulsed with OVA
beads and chased for various times, phagosomes were partially
purified, and phagosomal TLR4 was quantified by flow cytome-
try analysis. Whereas no labeling was detected on phagosomes
from Tlr4/ BMDCs, TLR4 was progressively recruited to phag-
osomes from 0 to 4 hr in WT, pearl, and pallid DCs; however, the
recruitment to pearl phagosomes was specifically and signifi-
cantly reduced by 30%–40% (Figures 6A and 6B). This result794, May 25, 2012 ª2012 Elsevier Inc. 787
Figure 6. AP-3 Is Required for Optimal TLR4 and MyD88 Recruitment to Phagosomes
(A–F, H, I) BMDCs fromWT, pallid, pearl, or Tlr4/mice were pulsed with OVA beads and chased as indicated. Phagosomes were purified, fixed, permeabilized,
and stained with FITC-conjugated TLR4 antibody (A, B) or with AP-3 antibody and Dylight 549 anti-mouse Ig (E, F) or with MyD88 or TRAM antibodies and Dylight
549 anti-rabbit Ig (H, I) or negative controls.
(A and H) Shown are histogram plots of representative experiments with the percentages of gated phagosomes that were positive for TLR4, MyD88, or TRAM
indicated. Black lines show unstained or secondary antibody-only stained controls.
(B, F, I) Data from three to five independent experiments are represented as mean ± SD.
(E) Histogram plot shows overlaid staining of AP-3 on WT (red) and pearl (green) phagosomes. Individual plots are shown in Figure S6.
(C and D) Purified phagosomes were analyzed by SDS-PAGE and immunoblotting for TLR4 (C), MyD88, TRAM (D), or actin as indicated. Shown are the relevant
bands from each blot.
Immunity
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788 Immunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc.
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AP-3, TLR, and MHC-II Presentation from Phagosomeswas confirmed by immunoblotting with phagosomes that were
magnetically isolated from homogenates of cells that had in-
gested OVA-coated magnetic beads (Figure 6C). Furthermore,
a small pool of TLR4 was detected by immunofluorescence
confocal microscopy surrounding a subset of phagosomes
3 hr after phagocytosis of OVA beads in wild-type DCs, but
less frequently in pearl DCs (Figure 6G). By contrast to TLR4,
both the lysosomal membrane protein LAMP2 and the MHC-II
molecule I-Ab were recruited to phagosomes with similar
kinetics and efficiency in both WT and pearl BMDCs (Figures
S6A–S6D). Thus, TLR4 undergoes AP-3-dependent recruitment
froman intracellular pool to late-stage phagosomes in DCs. AP-3
itself was detected on early phagosomes in wild-type DCs
but was less abundant on late phagosomes (Figures 6E, 6F,
and S6E).
Ligand-stimulated TLR4 recruits two different sets of signaling
adaptor proteins, TIRAP/MyD88 and TRAM/TRIF (Kawai and
Akira, 2011). TIRAP and MyD88 stimulate an early proinflamma-
tory response via MAP kinases and NF-kB and are thought
to signal mainly from the plasma membrane (Kagan et al.,
2008), although MyD88 is also recruited to E. coli-containing
phagosomes (Husebye et al., 2010). TRAM and TRIF stimulate
type I interferon production via IRF3 and a late-phase proinflam-
matory response from intracellular sites. By flow cytometry
and immunoblot analyses of phagosomes purified over time,
both MyD88 and TRAM were progressively recruited to phago-
somes in WT BMDCs (Figures 6D, 6H, and 6I). Although TRAM
was recruited to WT and pearl phagosomes at similar levels,
MyD88 recruitment was reduced by approximately 50% in pearl
phagosomes (Figures 6D, 6H, and 6I). Thus, optimal recruitment
of the proinflammatory TLR adaptor to phagosomes requires
AP-3.
AP-3 Is Required for Proinflammatory Signaling
from Phagosomes
We next tested whether the impaired TLR4 and MyD88 recruit-
ment in pearl BMDCs affected signaling from phagosomes.
BMDCs derived from WT, pallid, and pearl mice were incubated
with LPS-containing preparations of OVA or ligands for TLR2
(peptidoglycan), TLR3 (poly(I:C)), TLR4 (LPS), TLR5 (flagellin),
TLR7/8 (R848), or TLR9 (CpG) either in soluble or particulate
(coated on polystyrene beads) form, and proinflammatory
signaling was measured by stimulation of IL-6 or IL-12- and
IL-23p40 secretion into culture supernatants. As previously
shown in pDCs and BMDCs (Sasai et al., 2010), soluble TLR
ligands elicited secretion of comparable levels of IL-6 and p40
from WT, pallid, and pearl BMDCs (Figures 7A and S7). By
contrast, the same ligands in particulate form elicited signifi-
cantly (40%–50%) reduced cytokine secretion from pearl
BMDCs compared to their WT or pallid counterparts (Figures
7A and S7). Consistently, by qPCR array analysis, IL-6,
IL-12p35, and IL-12p40 mRNAs were induced to similar levels
inWT and pearl BMDCs in response to soluble LPS but induction
was 50% reduced in pearl BMDCs in response to LPS beads(G) BMDCs from WT and pearl mice were pulsed with LPS-coated beads and cha
AP3 (green) antibodies and fluorochrome-conjugated secondary antibodies, an
asterisks denote unlabeled phagosomes. Differential interference contrast (DIC)
*p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S6.(Figure 7B). By contrast, both soluble and particulate LPS
induced IFN-b1 mRNA to comparable levels in both WT and
pearl BMDCs. These data are consistent with the reduced
recruitment of MyD88 to phagosomes in pearl BMDCs and the
unimpaired recruitment of TRAM (Figures 6D, 6H, and 6I).
Thus, whereas both AP-3 and BLOC-1 are dispensable for cyto-
kine signaling from the plasma membrane or endosomes, AP-3
is specifically required for efficient proinflammatory TLR signal-
ing from phagosomes.
To further probe AP-3-dependent TLR4 signaling from phago-
somes, we examined downstream effectors of MyD88 and TRIF
pathways. Phosphorylation of MAP kinase p38 is stimulated with
different kinetics by MyD88 or TRIF signaling, and IRF3 phos-
phorylation is entirely TRIF dependent (Kawai and Akira, 2011).
As expected based on the cytokine secretion profiles, p38 and
IRF3 were both phosphorylated with similar kinetics in WT and
pearl BMDCs upon stimulation with soluble LPS (Figures 7C,
left, and 7D). IRF3 phosphorylation also followed similar kinetics
after phagocytosis of LPS beads in WT and pearl BMDCs
(Figures 7C, right, and 7D; note that the kinetics differed in
response to soluble LPS), consistent with the similar IFN-b1
mRNA induction in both cell types. By contrast, whereas both
WT and pearl BMDCs responded to LPS beads with robust
p38 phosphorylation, the phospho-p38 signal was sustained
longer in WT than in pearl BMDCs (Figure 7C, right), remaining
2-fold over background at 2 and 3 hr after phagocytosis only in
WT BMDCs (Figure 7D, left). These data suggest that whereas
initial MyD88-dependent TLR4 signaling does not require AP-3,
a second phase of MyD88-dependent signaling from phago-
somes requires AP-3 and is necessary for optimal induction of
proinflammatory responses. We propose that this second phase
of signaling also stimulates MHC-II presentation of phagocy-
tosed Ag.
DISCUSSION
TLR signaling from phagosomes stimulates effective processing
of phagocytosed Ag and ultimate presentation to CD4+ T cells
(Blander and Medzhitov, 2006b). Our data show that AP-3 plays
a critical role in this process by facilitating the delivery of TLR4,
probably other TLRs, and downstream signaling components
to maturing phagosomes. We show that this recruitment is
necessary for optimal proinflammatory signaling and correlates
with export of peptide-loaded MHC-II complexes to the plasma
membrane. Thus, in response specifically to phagocytosed anti-
gens, AP-3-deficient pearl DCs are markedly impaired in Ag
presentation and subsequent stimulation of effective Th1 cell
responses in vitro and in vivo. Defective Ag presentation is not
due to reduced Ag processing, but rather to peptide:MHC-II
complex retention within intracellular stores. Our data reveal an
important role of AP-3 in intracellular trafficking to and from
phagosomes, a requirement for phagosomal TLR signaling in
regulating both proinflammatory responses and mobilization
of peptide:MHC-II complexes from phagosomes, and insightssed for 3 hr. Cells were then fixed, permeabilized, labeled with TLR4 (red) and
d analyzed by confocal microscopy. Arrows indicate labeled phagosomes;
images (bottom) show phagocytosed beads.
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Figure 7. AP-3 Is Required for Optimal
Inflammatory Cytokine Production Induced
by Particulate TLR Ligands
(A) BMDCs from WT, pallid, or pearl mice were
incubated for 3 hr with soluble TLR ligands
LPS (50 ng/ml), OVA (1 mg/ml), flagellin (Flag.;
10 mg/ml), peptidoglycan (PGN; 10 mg/ml),
poly(I:C) (100 mg/ml), or R848 (0.1 mg/ml) or with
the indicated ligand-coated or uncoated latex
beads, and IL-6 released into the supernatants
was measured by ELISA.
(B) BMDCs from WT or pearl mice were incubated
in the presence or absence of LPS or LPS-coated
beads for 2 hr. cDNA generated from isolated RNA
was analyzed by real-time PCR. Data for mRNA
levels of IL-12p35, IL-12p40, IL-6, and IFN-b1 from
three independent experiments were normalized
to the average of five housekeeping genes, and
DDCt values were calculated and represented as
fold induction of mRNA in stimulated cells relative
to unstimulated cells.
(C and D) BMDCs from WT or pearl mice were
stimulated with LPS or LPS-coated beads for the
indicated times, and cell lysates were analyzed by
immunoblotting for phospho-p38, p38, phospho-
IRF3, and IRF3.
(C) Shown are the relevant regions of representa-
tive blots. Arrows, phospho-IRF3-specific band;
asterisks, a nonspecific band.
(D) Quantification of band intensities performed on
three independent experiments, showing the fold
increase in phospho-p38 (left) and phospho-IRF3
(right) levels relative to unstimulated cells and
normalized to total protein levels of p38 or IRF3,
respectively.
(A, B, D) Data from at least three independent
experiments are represented as mean ± SD.
*p < 0.05. See also Figure S7.
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HPS type 2 patients.
Nascent phagosomes in DCs fuse with a NOX2-bearing inhib-
itory LRO to promote alkalinization and consequent optimal Ag
cross-presentation (Jancic et al., 2007; Mantegazza et al.,
2008; Savina et al., 2006). We predicted that DC inhibitory
LROs, like other LROs, would be malformed in mouse HPS
models, consequently impairing cross-presentation. Surpris-
ingly, cross-presentation was equally efficient in WT, pearl, and
pallid DCs regardless of the mode of Ag internalization. This
might indicate that neither AP-3 nor BLOC-1 is required for inhib-
itory LRO formation. Alternatively, NOX2 might be missorted to
the plasma membrane in the absence of AP-3 or BLOC-1, as790 Immunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc.observed for other LRO cargoes (Clark
et al., 2003; Dell’Angelica et al., 1999; Di
Pietro et al., 2006), and incorporated
directly into newly formed phagosomes,
circumventing the need for an LRO in
cross-presentation. This might explain
the increased pH of nascent phago-
somes in pearl and pallid DCs.
Our results show that AP-3 plays a
heretofore unappreciated role in MHC-II-dependent presentation of phagocytosed Ag in DCs. Relative
to wild-type DCs, pearl DCs in vitro or in vivo elicited delayed and
less potent stimulation of Ag-specific CD4+ T cells only when
Ag was ingested by phagocytosis. The diminution in T cell
priming reflected decreased surface expression of pepti-
de:MHC-II complexes. Upon restimulation, CD4+ T cells primed
by particulate Ag-pulsed pearl DCs were less apt to secrete
IFN-g, consistent with a higher threshold of Ag stimulation
for effective Th1 cell responses (Constant et al., 1995) and
with the reduced TLR-stimulated IL-12 release that we show
here. IFN-g responses by Ag-specific T cells in vivo were
profoundly reduced in pearl mice in response to infection with
recombinant L. monocytogenes, suggesting that the defects
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antibacterial responses in vivo. A weakened early response by
poorly activated DCs can blunt subsequent innate and adaptive
responses as in Toxoplasma gondii infection (Hou et al., 2011)
and thus might in part explain the recurrent bacterial infections
in AP-3-deficient HPS type 2 patients.
A requirement for AP-3 in optimal MHC-II Ag presentation was
apparent only when Ag was internalized by phagocytosis. Pearl
DCs were as effective as WT DCs at presenting soluble OVA or
Ea, supporting earlier reports that AP-3 is dispensable for
MHC-II trafficking and peptide loading (Caplan et al., 2000;
Sevilla et al., 2001).Whereas a phagocytosis-specific Ag presen-
tation defect is also observed in Atg5/ DCs (Lee et al., 2010),
the mechanism appears to be distinct; Atg5/ DCs are defec-
tive in phagolysosome formation (Lee et al., 2010), whereas the
normal kinetics of OVA degradation and phagosome recruitment
of lysosomal contents in pearl DCs suggest that phagolysosome
formation is unperturbed. Moreover, Ea:I-Ab peptide:MHC-II
complexes formed with similar efficiency in pearl and WT DCs.
Thus, AP-3 is required not for Ag processing, but rather for
efficient plasma membrane delivery of peptide:MHC-II com-
plexes that derive from phagosomes. Surprisingly, these pepti-
de:MHC-II complexes accumulate in punctate postphagosomal
compartments that resemble those observed in DCs infected by
Leishmania major (Muraille et al., 2010) and do not harbor
markers of early or late endosomes or lysosomes. We speculate
that they represent intermediates in the redistribution of MHC-II
into tubular structures that ultimately fuse with the cell surface
(Boes et al., 2002; Chow et al., 2002).
How does AP-3 regulate this process?We suggest that defec-
tive surface delivery of peptide:MHC-II complexes in pearl DCs
is secondary to impaired phagosomal TLR recruitment and
phagosome-intrinsic TLR inflammatory signaling. The latter is
a known requirement for Ag presentation (Blander and Medzhi-
tov, 2006a), and TLR signaling is required for MHC-II redistribu-
tion to the plasma membrane in DCs (Boes et al., 2002; Chow
et al., 2002). Whereas soluble TLR ligands elicitedWT proinflam-
matory responses from pearl DCs, particulate TLR ligands
elicited diminished responses; the magnitude of the reduction
in the proinflammatory response was similar to that of presenta-
tion of phagocytosed Ag. This implies that TLR-dependent
signaling in DCs is more tightly regulated from phagosomes
than from the plasma membrane or endosomes, consistent
with the need to present foreign Ags and not self Ags on phago-
cytosed apoptotic cells (Blander and Medzhitov, 2006b). The
observed defects correlated with impaired recruitment of TLR4
and MyD88 from intracellular stores, as in Rab11-depleted
macrophages (Husebye et al., 2010). Although we focused on
TLR4, phagosomal delivery of other TLRs such as TLR2—previ-
ously documented in macrophages (Underhill et al., 1999)—
probably also requires AP-3, because (1) inflammatory signaling
in pearl BMDCs by ligands of TLR2, TLR3, TLR5, and TLR7 was
also impaired only when coated on beads; (2) presentation of
OVA from rLM, which stimulates TLR2 and/or TLR5 but not
TLR4 (Flo et al., 2000; Hayashi et al., 2001), was also impaired
in pearl DCs; (3) MyD88 recruitment to phagosomes in pearl
BMDCs is more strikingly reduced than TLR4; and (4) preliminary
proteomics analysis showed fewer TLR2- and TLR7-derived
peptides on phagosomes from pearl than from WT BMDCs2 hr after uptake of OVA-coated beads (data not shown). The
requirement for AP-3 in phagosomal inflammatory TLR signaling
in conventional DCs is reminiscent of its requirement in pDCs for
translocation of endosomal TLR7 and TLR9 to an LRO to
promote IRF7- and TRAF3-dependent signaling (Blasius et al.,
2010; Sasai et al., 2010). However, the mechanisms are clearly
distinct because in conventional DCs, AP-3 is not required for
TLR4 stimulation of the TRAM-TRIF pathway toward type I inter-
feron production, but rather is necessary for optimal MyD88
recruitment to phagosomes, with subsequent sustained p38
phosphorylation and TLR-dependent proinflammatory cytokine
production. Importantly, our data provide evidence that a second
wave of MyD88-dependent signaling from DC phagosomes is
necessary for optimal proinflammatory responses to phagocy-
tosed particles and probably for downstreamMHC-II Ag presen-
tation. Given that phagosomal degradative capacity and acqui-
sition of lysosomal markers proceeded normally in pearl
BMDCs but not in Tlr4/ BMDCs (Blander and Medzhitov,
2004; and our results), it is tempting to speculate that the first
phase of MyD88 signaling from the plasma membrane, which
is maintained in the absence of AP-3, would be sufficient to
ensure phagosome maturation and MHC-II peptide loading.
How AP-3 regulates TLR4-MyD88 delivery to phagosomes is
not clear, but it is unlikely to bind directly to the TLR4 cyto-
plasmic domain. Although potential consensus tyrosine-based
AP-3-binding sorting signal sequences (Ohno et al., 1998) are
present in most TLR cytoplasmic domains, they are in regions
that are buried in the crystal structures of the TLR1 and TLR2
TIR domains and thus probably unavailable for binding (Xu
et al., 2000); consistently, we could not detect an interaction
between the TLR4 TIR domain and the m chains of AP-3 by yeast
two-hybrid assay (data not shown). AP-3 might directly engage
a TLR-associated inflammatory adaptor when in complex with
TLR4, a novel binding interface on TLR4, or an as-yet-unidenti-
fied traffickingadaptor.Alternatively, itmightdelivera recruitment
factor required for fusion of TLR4-containing transport intermedi-
ates from endosomes. Our data suggest that AP-3 might also
play a secondary role in phagosome maturation beyond TLR
recruitment, because AP-3 itself accumulates on early phago-
somes and trails off later when TLR4, MHC-II, and lysosomal
markers appear. This suggests that AP-3 might function in cargo
trafficking not only to phagosomes but also from phagosomes.
One potential destination for this trafficking is the vesicular
compartment in which peptide:MHC-II complexes accumulate
and from which they appear to be exported. It is intriguing to
speculate that AP-3 facilitates transport of peptide:MHC-II
complexes, activated TLR signaling complexes, and/or other
regulatory components from phagosomes to these compart-
ments and/or the subsequent formation of plasma membrane-
bound tubules from them. How AP-3-dependent inflammatory
signaling from phagosomes supports these late events in Ag
presentation provides a new venue for future research.
EXPERIMENTAL PROCEDURES
Mice, Cell Culture, and Antibodies
Sex- and age-matched mice between 6 and 12 weeks of age were used in all
experiments. Mice were housed and bred under pathogen-free conditions in
accordance with Institutional Animal Care and Use Committee-approved
protocols at the University of Pennsylvania School of Veterinary MedicineImmunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc. 791
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AP-3, TLR, and MHC-II Presentation from PhagosomesAnimal Facility or at the Children’s Hospital of Philadelphia. See Supplemental
Experimental Procedures for details on mouse strains. BMDCs were cultured
for 7–9 days in granulocyte-macrophage colony stimulating factor-supple-
mented medium, splenic DCs were isolated by both negative and positive
selection, and OT-I and OT-II T cells were isolated by positive selection as
detailed in Supplemental Experimental Procedures. See Supplemental Exper-
imental Procedures for antibodies and other reagents and additional proce-
dure details.
Ag Presentation Assays
DCs were exposed to OVA, OVA:BSA-coated 3 mm latex beads (Polysciences,
Warrington, PA), or OVA-specific MHC-I or MHC-II peptides for 15–30 min at
37C, thenwashed in PBS and chased in completemedium at 37C. DCswere
then either fixed with 0.5% paraformaldehyde (PFA) in PBS for 10 min (for OT-I
stimulation) or not (for OT-II), washed with PBS, and cultured with 5–10 3 104
CD8+ OT-I T cells or CD4+ OT-II T cells. T cell activation was monitored 18 hr
later as CD69 expression by flow cytometry (FACSCalibur, BD Biosciences,
San Diego, CA) and IL-2 secretion in coculture supernatants by ELISA (BD
Biosciences). At day 3 of coculture, IFN-g and IL-4 production was measured
by intracellular flow cytometry after a 5 hr restimulation with PMA plus ionomy-
cin or CD3 and CD28 antibodies with brefeldin A (Bougne`res et al., 2009). For
Ag presentation kinetics after OVA bead phagocytosis, BMDCs were fixed
with 0.5% PFA after different chase times and cocultured for 18 hr with pres-
timulated OT-II cells (Fitch et al., 2006). For presentation of Ea52-68 peptide on
I-Ab, BMDCs were incubated with 0.5 mg soluble EaGFP or EaGFP-coated
(5 mg/ml) beads for 30 min, washed with PBS, and chased. Cells were then
fixed with 3% PFA in PBS, stained with biotinylated Yae (clone eBioY-Ae,
eBioscience, San Diego, CA) and APC-streptavidin (Invitrogen), and analyzed
by flow cytometry. Intracellular Ea52-68:I-A
b complexes were detected by flow
cytometry by means of biotinylated Yae after saturating the cell surface with
unlabeled antibody (Lee et al., 2010). Yae labeling was quantified on CD11c+
cells that had taken up one bead as gated on a forward scatter versus side
scatter plot (Lee et al., 2010).
Immunofluorescence Microscopy
BMDCs were fixed with 3% formaldehyde in PBS, permeabilized with
Permwash (BD), and labeled with primary antibodies and Alexa Fluor- or
Dylight-conjugated secondary antibodies (Calvo et al., 1999). Cells were
analyzed by fluorescence microscopy with a Zeiss LSM 710 confocal micro-
scope and Zeiss ZEN 2010 software, or with a DM IRBE microscope (Leica
Microsystems, Wetzlar, Germany) and an Orca digital camera (Hamamatsu,
Bridgewater, NJ) with OpenLab software (Improvision, Waltham, MA). For
the latter, images obtained from consecutive z planes were processed by
subtractive volume deconvolution.
In Vivo Infection
OVA-secreting or nonsecreting Listeria monocytogenes Dhly2 strain (rLM-
OVA, rLM) were grown as described (Foulds et al., 2002). WT and pearl mice
(CD45.2+) were injected intravenously (i.v.) with 50,000 CFU of rLM-OVA or
rLM or OVA in 200 ml of PBS. In some mice, splenic DCs were isolated 24 hr
or 3 days later and cocultured with OT-I or OT-II cells for analysis of T cell
CD69 induction. In other mice, 3 3 106 CD45.1+, CFSE-labeled OT-II cells
were transferred i.v. 24 hr before immunization. Spleen and lymph nodes
were harvested either 18 hr postinfection to measure CD69 expression on
OT-II cells by flow cytometry or 8 days postinfection and T cells assayed
for IL-4 and IFN-g by intracellular flow cytometry after restimulation in vitro
(Bougne`res et al., 2009).
Phagosome Purification and Protein Recruitment
BMDCs were incubated for 15 min with OVA-coated latex beads or 3 mm
magnetic beads (Dynabeads M-280 streptavidin, Invitrogen, NY) and then
chased. Magnetic and nonmagnetic phagosomes were purified after different
chase times by means of a magnet or differential centrifugation, respectively,
as described (Guermonprez et al., 2003; Mantegazza et al., 2008). Purified
OVA-bead phagosomes were fixed, permeabilized, stained with antibodies
to AP-3, TLR-4, MyD88, TRAM, I-Ab, LAMP2, or negative controls, and
analyzed concurrently by flow cytometry, gating on the OVA-positive bead
population (Savina et al., 2010). Protein extracts from purified magnetic phag-
osomes were analyzed by immunoblotting.792 Immunity 36, 782–794, May 25, 2012 ª2012 Elsevier Inc.Cytokine Secretion after TLR Stimulation
To generate TLR ligand-coated beads, TLR ligands were incubated overnight
in PBS with 3 mm latex beads and extensively washed with endotoxin-tested
PBS (Invitrogen). BMDCs were incubated in complete medium supplemented
as indicated with soluble TLR ligand or TLR ligand-coated beads for 3 hr as
described (Sepulveda et al., 2009). Cytokine concentration in culture superna-
tants was measured by ELISA (ELISA Ready-SET-Go! Mouse interleukin-6,
mouse interleukin-23 [p19-p40] and mouse interleukins-12 and -23 [total
p40], eBioscience).
Real-Time RT-PCR
RNA was isolated with RNeasy (QIAGEN, CA) fromWT and pearl BMDCs after
2 hr incubation with or without LPS (50 ng/ml) or LPS-coated beads. 1 mg RNA
was reverse transcribed to cDNA via RT2 First Strand (QIAGEN). Real-time
PCR was performed in a 7300 ABI PCR System (Applied Biosystems, CA)
with RT2 SYBR Green/ROX PCR mastermix and the Mouse Antibacterial
Response RT2 Profiler PCR array (96-well format, SABiosciences, QIAGEN).
Data were normalized to the average of five housekeeping genes. Relative
levels of IL-6, IL-12p35, IL-12p40, and IFN-b1 mRNA were calculated with
the DDCt method (Caino et al., 2011) and represented as mRNA fold-induction
compared to unstimulated cells.
Immunoblotting
For TLR signaling, WT and pearl BMDCs were stimulated with LPS (50 ng/ml)
or LPS-coated beads, chased as indicated, and lysed as described
(Proietti et al., 2005). Proteins were fractionated by 10% or 12% SDS-PAGE
and analyzed by immunoblotting with alkaline-phosphatase-conjugated
secondary antibodies, enhanced chemifluorescent substrate (GE Healthcare,
Buckinghamshire, UK), and phosphorimaging (Berson et al., 2001). Densito-
metric analysis on the bands was performed with NIH Image J software
normalizing to total protein levels.
Statistical Analysis
Statistical significance was determined by unpaired Student’s t test and anal-
ysis of variance. *p < 0.05, **p < 0.01, and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/
j.immuni.2012.02.018.
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